Advanced Search

 

Study ID Status Title Patient Level Data
117156 Completed A randomised, repeat-dose, placebo-controlled, three-way crossover, double dummy study to evaluate and compare the efficacy of Fluticasone Furoate inhalation powder delivered via the single strip dry powder inhaler when administered either in the morning or in the evening, in male and female asthmatic subjects Study Listed on ClinicalStudyDataRequest.com
117157 Completed Characterization of Exposure from Topical Administration of [14C] Umeclidinium to Axilla or Palm of Healthy Male Subjects Study Listed on ClinicalStudyDataRequest.com
117168 Completed A Phase I, Subject and Investigator Blind Randomized, Study to Investigate the Pharmacokinetics, Safety and Tolerability of Retosiban in Healthy Japanese Women
117170 Active not recruiting Analysis Plan for the Integrated Analysis of Cardiovascular Risk Among Type II Diabetes Subjects Exposed to GSK716155 in the Phase III Program
117171 Completed A two-part healthy volunteer study to investigate both the interaction of GSK2586184 with Rosuvastatin and Simvastatin and to compare the pharmacokinetics of two different formulations of GSK2586184
117176 Completed AN OPEN LABEL, BALANCED, RANDOMIZED, TWO-TREATMENT, TWO-PERIOD, TWO-SEQUENCE, CROSSOVER, SINGLE ORAL DOSE, BIOEQUIVALENCE STUDY OF MELOXICAM GSK 15 MG TABLETS MANUFACTURED BY SAVIPHARM J.S.C, VIETNAM AND MOBIC® 15 MG TABLETS OF BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG BINGER STR.173, 5521 INGELHEIM AM RHEIN, GERMANY, IN HEALTHY, ADULT, HUMAN MALE SUBJECTS UNDER FED CONDITION.
117177 Completed Consistency, immunogenicity and safety study of GSK Biologicals’ Herpes Zoster vaccine GSK1437173A in adults 50 years of age or older
117183 Completed Efficacy and safety of alitretinoin in the treatment of severe chronic hand eczema refractory to topical therapy
117191 Completed An Evaluator-Blinded Study to Evaluate the Cumulative Irritation Potential of Topically-Applied GSK2894512 Cream in Healthy Subjects
117211 Completed Plan to Assess the incidence of cardiovascular related adverse events in controlled clinical trials of bupropion for the treatment of smoking cessation
117212 Completed Validation of Lupus Impact Tracker™ in five European clinical practice settings
117213 Completed A randomised, double-blind, placebo-controlled study to evaluate the safety, tolerability, pharmacokinetics and pharmacodynamics of repeat doses of GSK2330672 administration in patients with primary biliary cirrhosis (PBC) and symptoms of pruritus
117214 Recruiting Evaluation Of Use of Belimumab in Clinical Practice SEttings (OBSErve) - Observations from Germany
117218 Completed A focus on patients with CHE: Recording of influential factors on the quality of life, work productivity and progression of treatment while taking Toctino®
117219 Completed Oral bioavailability study comparing OXEMET™ 1000 mg coated tablets containing metformin hydrochloride with 1000 mg of the reference product (GLAFORNIL™) administered as two 500 mg tablets, through a randomized, single-dose, open label, balanced, 2-way crossover study in healthy volunteers under fasting conditions.OXEMET (TM) is a trademark of the GlaxoSmithKline group of companies. GLAFORNIL(TM) is a trademark of Merck. Study Listed on ClinicalStudyDataRequest.com
117221 Completed Efficacy of oral alitretinoin treatment in patients with palmo-plantar pustulosis (PPP) inadequately responding to standard topical treatment Study Listed on ClinicalStudyDataRequest.com
117225 Completed A Single-Blind Study to Evaluate the Irritation Potential of Repeat Topical Applications of GSK1940029 Gel on the Intact Skin of Healthy Human Subjects and Acne Patients
117226 Completed A Randomized, Single-Blind, Dose-Rising Study to Evaluate the Safety, Tolerability and Preliminary Pharmacokinetics of Single and 14 Day Repeat Topical Applications of GSK1940029 Gel on the Intact Skin of Healthy Human Subjects
117233 Completed Burden of mild outcomes due to influenza in the United States, July 2000 through April 2009 and October 2010 to May 2011
117235 Recruiting BAP02147: POST-MARKETING OBSERVATIONAL STUDY OF THE ACTUAL USE, EFFECTIVENESS AND SAFETY OF TOCTINO® (ALITRETINOIN) IN THE TREATMENT OF CHRONIC HAND ECZEMA
117236 Recruiting BAP02147: OBSERVATIONAL STUDY TO COMPARE CLINICAL SCORES AND EXPERT PHOTOGRAPH SCORES IN PATIENTS WITH SEVERE CHRONIC HAND ECZEMA BEFORE AND AFTER TREATMENT WITH ORAL ALITRETINOIN (TOCTINO®)
117245 Terminated Estimation of Skeletal Muscle Mass with Deuterium Labeled d3 Creatine in Subjects with Chronic Disease
117249 Completed Characterisation of the T-cell response in Delayed Type Hypersensitivity reactions to Keyhole Limpet Hemocyanin (KLH) and Tuberculin Purified Protein Derivative (PPD) in Healthy Volunteers
117254 Active not recruiting Systematic review and quantitative analysis of dabrafenib and trametinib therapies in the treatment of metastatic malignant melanoma
117255 Completed GHO-07-0392 Pazopanib EU RCC Chart Study

 

 

For more information on this register please email GSKClinicalSupportHD@gsk.com

GSK-sponsored clinical studies are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.
GSK-sponsored clinical trials are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.

ClinicalTrial.gov is a database that provides summary protocol information for ongoing clinical trials.

IFPMA.org is a search portal provided by the International Federation of Pharamceutical Manufacturers & Associations (IFPMA).

This portal provides a single entry point to search for industry sponsored clinical trials which are on existing registers and databases.

EU Clinical Trials Register is a database of all clinical trials commencing in the European Community from 1 May 2004 onwards. It has been established in accordance with Directive 2001/20/EC.